PATENT CLAIM ANALYSIS

Application Number: 15756798
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["536", "023100"]

Abstract:
The invention relates to a combination and its use for the treatment of diseases. The instant disclosure provides a combination of a so-called T-cell regulator selected from the group comprising PD1, PD-L1, OX40, TIM-3, LAG3, CD137(4-1BB) and a non-coding immunomodulating DNA.

Claim (Index 6):
The combination of  claim 3 , wherein the linear open-chained non-coding sequence of deoxyribonucleic acids comprises at least one nucleotide in L-conformation.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.34211
- Patent Class: 536.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10057311', '14046044', '12442295', '11549048', '11743876']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6543071290358711
- 35 USC 102 Novelty (BERT): 0.5069986680747923
- Combined Prediction Score: 0.6395762829397633
- Mean Citation Score: 284.0886240000001
- Max Citation Score: 291.83954
- Similarity Product: 214.7466222689164

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test